Opiant

$13.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.46 (+3.63%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Opiant and other stocks, options, and ETFs commission-free!

About OPNT

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA. The listed name for OPNT is Opiant Pharmaceuticals, Inc. Common Stock.

CEO
Roger Crystal
Employees
21
Headquarters
Santa Monica, California
Founded
2005
Market Cap
59.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
33.76K
High Today
$13.16
Low Today
$12.70
Open Price
$12.92
Volume
14.66K
52 Week High
$14.98
52 Week Low
$6.79

OPNT Earnings

-$2.13
-$0.76
$0.60
$1.97
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.07 per share
Actual
Available Mar 4, After Hours

You May Also Like

BAK
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure